Download
s00415-020-09847-8.pdf 1,02MB
WeightNameValue
1000 Titel
  • Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy
1000 Autor/in
  1. Osmanovic, Alma |
  2. Ranxha, Gresa |
  3. Kumpe, Mareike |
  4. Müschen, Lars |
  5. Binz, Camilla |
  6. Wiehler, Flavia |
  7. Paracka, Lejla |
  8. Körner, Sonja |
  9. Kollewe, Katja |
  10. Petri, Susanne |
  11. Schreiber-Katz, Olivia |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-05-02
1000 Erschienen in
1000 Quellenangabe
  • 267(8):2398-2407
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00415-020-09847-8 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359174/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!The antisense-oligonucleotide (ASO) nusinersen has recently been approved as the first genetically modifying therapy for 5q-associated spinal muscular atrophy (SMA) based on randomized sham-controlled trials in infants and children. The efficacy in adults with long disease history and advanced disease status is still widely unknown; the same applies to specific expectations of adult SMA patients and to what extent they are met and may impact outcome measures.!##!Methods!#!In a longitudinal monocentric study in adult patients with SMA types 2-4, the Stanford Expectations of Treatment Scale (SETS) was assessed prior to and during nusinersen treatment. Treatment outcome was evaluated using patient-reported outcomes (PROs) as well as objectively quantifiable motor outcome measures.!##!Results!#!Adult SMA patients had high expectations of nusinersen treatment effectiveness regarding increase in muscle strength and disease stabilization. Via PROs, 75% stated improvements in muscle strength, endurance and independence under therapy which was in line with slight improvements in quantifiable motor scores during a  ten month observation period. In contrast, patients only expressed few negative expectations which further decreased during therapy.!##!Conclusions!#!This study showed mainly positive treatment expectations and PROs in patients undergoing nusinersen treatment along with measurable functional improvement in adult SMA patients. Moreover, treatment expectations did not significantly influence outcome measures.
1000 Sacherschließung
lokal Spinal muscular atrophy (SMA)
lokal Antisense-oligonucleotide (ASO)
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Spinal Muscular Atrophies of Childhood [MeSH]
lokal Patient-reported outcomes (PROs)
lokal Stanford expectations of treatment scale (SETS)
lokal Oligonucleotides [MeSH]
lokal Patient Reported Outcome Measures [MeSH]
lokal Infant [MeSH]
lokal Muscular Atrophy, Spinal/drug therapy [MeSH]
lokal Nusinersen
lokal Motivation [MeSH]
lokal Original Communication
lokal Child [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/T3NtYW5vdmljLCBBbG1h|https://frl.publisso.de/adhoc/uri/UmFueGhhLCBHcmVzYQ==|https://frl.publisso.de/adhoc/uri/S3VtcGUsIE1hcmVpa2U=|https://frl.publisso.de/adhoc/uri/TcO8c2NoZW4sIExhcnM=|https://frl.publisso.de/adhoc/uri/QmlueiwgQ2FtaWxsYQ==|https://frl.publisso.de/adhoc/uri/V2llaGxlciwgRmxhdmlh|https://frl.publisso.de/adhoc/uri/UGFyYWNrYSwgTGVqbGE=|https://frl.publisso.de/adhoc/uri/S8O2cm5lciwgU29uamE=|https://frl.publisso.de/adhoc/uri/S29sbGV3ZSwgS2F0amE=|https://frl.publisso.de/adhoc/uri/UGV0cmksIFN1c2FubmU=|https://frl.publisso.de/adhoc/uri/U2NocmVpYmVyLUthdHosIE9saXZpYQ==
1000 Hinweis
  • DeepGreen-ID: 1111c0e725d446d1aceb2df087f59c49 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6469702.rdf
1000 Erstellt am 2023-11-18T00:50:33.150+0100
1000 Erstellt von 322
1000 beschreibt frl:6469702
1000 Zuletzt bearbeitet Fri Dec 01 10:21:58 CET 2023
1000 Objekt bearb. Fri Dec 01 10:21:58 CET 2023
1000 Vgl. frl:6469702
1000 Oai Id
  1. oai:frl.publisso.de:frl:6469702 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source